Source link : https://www.newshealth.biz/health-news/antibody-drug-conjugate-tackles-glucocorticoid-use-in-pmr/
TOPLINE: ABBV-154, an antibody-drug conjugate comprising adalimumab conjugated to a proprietary glucocorticoid receptor modulator, shows potential for extending flare-free periods in patients with glucocorticoid-dependent polymyalgia rheumatica (PMR), with the ability to reduce glucocorticoid dose. METHODOLOGY: In a phase 2 randomized controlled trial conducted across 70 centers in multiple countries, researchers evaluated the efficacy and safety […]
Author : News Health
Publish date : 2025-02-04 05:23:09
Copyright for syndicated content belongs to the linked Source.